Additional studies reveled that PD-L1 expression by breast cancer cells contributes to the expression of the IFN-related DNA damage resistance signature (IRDS), a subset of IFN-induced genes that protect cancer cells from DNA damage. This evidence concerns the gene IFNA1 and breast cancer.